[1] LI HT, LIU HH, YANG YX, et al.Therapeutic effects of a traditional Chinese medicine formula plus tamoxifen vs tamoxifen for the treatment of mammary gland hyperplasia: a meta-analysis of randomized trials[J]. Front Pharmacol, 2018, 9: 45. [2] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. [3] LIU SW, CHEN YB, et al.Mechanism of Prunellae Spica against breast disease: a review[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2022, 28(25): 250-255. [4] COTE ML, RUTERBUSCH JJ, ALOSH B, et al.Benign breast disease and the risk of subsequent breast cancer in African American women[J]. Cancer Prev Res(Phila), 2012, 5(12): 1375-1380. [5] JYU J, HONG WJ, GUO YF, et al.Understanding and research progress of traditional Chinese and Western medicine on mammary hyperplasia[C]. Proceedings of the 2016 Annual Conference of the Surgical Branch of the Chinese Association of Chinese Medicine (2016年中华中医药学会外科分会学术年会论文集), 2016: 249-255. [6] WANG Q, SUN SG, QIAO MQ.Comparative efficacy of RuPi SanJie capsule, tamoxifen and their combination for breast hyperplasia in China: a network Meta-analysis[J]. Chin J Hosp Parm(中国医院药学杂志), 2021, 41(9): 922-928. [7] LIU K, LI SD, WU XL, et al.Clinical observation on oral administration of Chaihu Shugan powder combined with external application of Sanjie Rupi Ointment in the treatment of breast hyperplasia[J]. CJGMCM(光明中医), 2019, 34(21): 3292-3294. [8] LYU CG, KANG CZ, ZHOU LY, et al.Discussion of present situation and further development of Chinese medicine dispensing granules standard research[J]. Mod Chin Med(中国现代中药), 2017, 19(6): 748-752. [9] ZONG Q, DONG LH, XUE R, et al.Matrix and in vivo and in vitro evaluation of cataplasma:research progress[J]. J Int Pharm Res(国际药学研究杂志), 2020, 47(10): 814-820. [10] HUANG YY, ZHENG HZ, WANG SX, et al.Study on the prescription and preparation process of compound Huoxue gel plasters[J]. Traditional Chinese Drug Research & Clinical Pharmacology(中药新药与临床药理), 2020, 31(2): 241-245. [11] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China,Volume IV(中华人民共和国药典四部)[M]. Beijing: China Medical Science Press, 2020. [12] PI FJ, ZHANG QL, XU Z, et al.Study on preparation technology of Hongma gel plaster[J]. Asia-Pacific Traditional Medicine(亚太传统医药), 2021, 17(7): 49-51. [13] ZHANG HW.Study on preparation and evaluation of antipyretic gel paster for children[D]. Beijing: Beijing University of Chinese Medicine, 2016. [14] PAN X, ZHANG LY, LI WJ, et al.Study on the preparation process of Huoluo Zhitong cataplasm[J]. Chinese Journal of Ethnomedicine and Ethnopharmacy(中国民族民间医药), 2022, 31(1): 60-62, 67. [15] ZHAO MQ, LIF, SHI BB, et al.Systems pharmacology (Ⅵ)-TCMSP database and application progress[J]. Information on Traditional Chinese Medicine(中医药信息), 2020, 37(3): 22-29. [16] DONG J, YAO ZJ, CAO DS.TargetNet: An online computing platform for multi-target QSAR to predict potential drug-target interactions[C], Proceedings of the 14th National Conference on Computational (Computer) Chemistry and International Forum on Molecular Simulation of Chinese Chemical Society(中国化学会第14届全国计算(机)化学学术会议暨分子模拟国际论坛论文集), 2017: 160-160. [17] AMBERGER JS, HAMOSH A.Searching online mendelian inheritance in man (omim): a knowledgebase of human genes and genetic phenotypes[J]. Curr Protoc Bioinformatics, 2017, 58(1): 1-2. [18] HAO H, TIAN GX, GENG H, et al.Introduction to the application of GeneCards, a comprehensive analysis database of human genes[J]. Chin J Evid Based Cardiovasc Med(中国循证心血管医学杂志), 2021, 13(8): 902-906. [19] HSIN KY, MATSUOKA Y, ASAI Y, et al.SystemsDock: a web server for network pharmacology-based prediction and analysis[J]. Nucleic Acids Res, 2016, 44(W1): W507-W513. [20] RAJARAM P, CHANDRA P, TICKU S, et al.Epidermal growth factor receptor: role in human cancer[J]. Indian J Dent Res, 2017, 28(6): 687-694. [21] JIN Y, WANG YH, YANG LX, et al.Expression and clinicopathological analysis of CK5/6,EGFR and AR in 953 cases of breast cancer[J]. Journal of Tianjin Medical University(天津医科大学学报), 2022, 28(1): 85-90. [22] ANESTIS A, ZOI I, PAPAVASSILIOU AG, et al.Androgen receptor in breast cancer-clinical and preclinical research insights[J]. Molecules, 2020, 25(2): 358. [23] BANERJEE K, RESAT H.Constitutive activation of STAT3 in breast cancer cells: a review[J]. Int J Cancer, 2016, 138(11): 2570-2578. [24] IMRAN M, RAUF A, ABU-IZNEID T, et al.Luteolin, a flavonoid, as an anticancer agent: a review[J]. Biomed Pharmacother, 2019, 112: 108612. [25] CHEN AY, CHEN YC.A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention[J]. Food Chem, 2013, 138(4): 2099-2107. [26] YOSHIDA GJ.Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways[J]. J Exp Clin Cancer Res, 2020, 39(1): 112. [27] HU C, HUANG L, GEST C, et al.Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells[J]. J Hematol Oncol, 2012, 5: 16. |